Advanced search
Publication Cover
Expert Review of Cardiovascular Therapy Volume 6, 2008 - Issue 9
Submit an article Journal homepage
118
Views
61
CrossRef citations to date
0
Altmetric
Review

HDL-replacement therapy: mechanism of action, types of agents and potential clinical indications

Alan T Remaley National Institutes of Health, Lipoprotein Metabolism Section, Pulmonary and Vascular Medicine Branch, National Heart, Lung, and Blood Institute, Building 10, Room 7N-115, 10 Center Drive, Bethesda, MD 20892-21508, USA. [email protected]
,
Marcelo Amar National Institutes of Health, Lipoprotein Metabolism Section, Pulmonary and Vascular Medicine Branch, National Heart, Lung, and Blood Institute, Bethesda, MD, USA
&
Dmitri Sviridov Baker Heart Research Institute, Melbourne, Australia
Pages 1203-1215 | Published online: 10 Jan 2014

Citations (61)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Yue Yuan, Jian Wen, Jie Tang, Qiming Kan, Rose Ackermann, Karl Olsen & Anna Schwendeman. (2016) Synthetic high-density lipoproteins for delivery of 10-hydroxycamptothecin. International Journal of Nanomedicine 11, pages 6229-6238.
Read now
Andrew Murphy, Jaye Chin-Dusting & Dmitri Sviridov. (2009) Reconstituted HDL: a therapy for atherosclerosis and beyond. Clinical Lipidology 4:6, pages 731-739.
Read now

Articles from other publishers (59)

Ahmed O. Elzoghby, Omar Samir, Ahmed Soliman, Sergey Solomevich, Minzhi Yu, Anna Schwendeman & Mahmoud L. Nasr. (2023) Nanodiscs: Game changer nano-therapeutics and structural biology tools. Nano Today 53, pages 102026.
Crossref
Holly C. Sucharski & Sara N. Koenig. 2022. Cardiovascular Signaling in Health and Disease. Cardiovascular Signaling in Health and Disease 343 365 .
Jaqueline Lourdes Rios, David A. Hart, Raylene A. Reimer & Walter Herzog. (2020) Prebiotic and Exercise Do Not Alter Knee Osteoarthritis in a Rat Model of Established Obesity. CARTILAGE 13:2_suppl, pages 1456S-1466S.
Crossref
Michelle W. Lee, Elizabeth Wei-Chia Luo, Carlos Silvestre-Roig, Yashes Srinivasan, Kiyotaka Akabori, Patricia Lemnitzer, Nathan W. Schmidt, Ghee Hwee Lai, Christian D. Santangelo, Oliver Soehnlein & Gerard C. L. Wong. (2021) Apolipoprotein Mimetic Peptide Inhibits Neutrophil-Driven Inflammatory Damage via Membrane Remodeling and Suppression of Cell Lysis. ACS Nano 15:10, pages 15930-15939.
Crossref
Rachana Bhoite, Anitha Chandrasekaran, Varalakshmi Lalithya Pratti, Vinita Satyavrat, Shivani Aacharya, Amey Mane, Suyog Mehta, Ravindra Machhindra Kale, Gayathri Nagamuthu, Sasikala Selvaraj, Gayathri Rajagopal, Sudha Vasudevan, Shobana Shanmugam, Anjana Ranjit Mohan, Ranjit Unnikrishnan, Kamala Krishnaswamy & Viswanathan Mohan. (2021) Effect of a High-Protein High-Fibre Nutritional Supplement on Lipid Profile in Overweight/Obese Adults with Type 2 Diabetes Mellitus: A 24-Week Randomized Controlled Trial. Journal of Nutrition and Metabolism 2021, pages 1-9.
Crossref
Anna Wolska, Mart Reimund, Denis O. Sviridov, Marcelo J. Amar & Alan T. Remaley. (2021) Apolipoprotein Mimetic Peptides: Potential New Therapies for Cardiovascular Diseases. Cells 10:3, pages 597.
Crossref
C. Michael Gibson, John J.P. Kastelein, Adam T. Phillips, Philip E. Aylward, Megan K. Yee, Michal Tendera, Stephen J. Nicholls, Stuart Pocock, Shaun G. Goodman, John H. Alexander, A. Michael Lincoff, Christoph Bode, Danielle Duffy, Mark Heise, Gail Berman, Sojaita Jenny Mears, Pierluigi Tricoci, Lawrence I. Deckelbaum, P. Gabriel Steg, Paul Ridker & Roxana Mehran. (2021) Rationale and design of ApoA-I Event Reducing in Ischemic Syndromes II (AEGIS-II): A phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to investigate the efficacy and safety of CSL112 in subjects after acute myocardial infarction. American Heart Journal 231, pages 121-127.
Crossref
Emily E. Morin, Yanhong Guo, Hongliang He, Wenmin Yuan, Whitney N. Souery, Maria V. Fawaz, Yuqing Eugene Chen & Anna Schwendeman. (2020) Synergetic Effect of rHDL and LXR Agonist on Reduction of Atherosclerosis in Mice. Frontiers in Pharmacology 11.
Crossref
Megan Shelby, Deepshika Gilbile, Thomas Grant, William Bauer, Brent Segelke, Wei He, Angela Evans, Natalia Crespo, Pontus Fischer, Tim Pakendorf, Vincent Hennicke, Mark Hunter, Alex Batyuk, Miriam Barthelmess, Alke Meents, Tonya Kuhl, Matthias Frank & Matthew Coleman. (2020) Crystallization of ApoA1 and ApoE4 Nanolipoprotein Particles and Initial XFEL-Based Structural Studies. Crystals 10:10, pages 886.
Crossref
Mark L. Schultz, Maria V. Fawaz, Ruth D. Azaria, Todd C. Hollon, Elaine A. Liu, Thaddeus J. Kunkel, Troy A. Halseth, Kelsey L. Krus, Ran Ming, Emily E. Morin, Hayley S. McLoughlin, David D. Bushart, Henry L. Paulson, Vikram G. Shakkottai, Daniel A. Orringer, Anna S. Schwendeman & Andrew P. Lieberman. (2019) Synthetic high-density lipoprotein nanoparticles for the treatment of Niemann–Pick diseases. BMC Medicine 17:1.
Crossref
Eva L van der Linden, Karlijn Meeks, Erik Beune, Ama de-Graft Aikins, Juliet Addo, Ellis Owusu-Dabo, Frank P Mockenhaupt, Silver Bahendeka, Ina Danquah, Matthias B Schulze, Joachim Spranger, Kerstin Klipstein-Grobusch, Lambert Tetteh Appiah, Liam Smeeth, Karien Stronks & Charles Agyemang. (2019) The prevalence of metabolic syndrome among Ghanaian migrants and their homeland counterparts: the Research on Obesity and type 2 Diabetes among African Migrants (RODAM) study. European Journal of Public Health 29:5, pages 906-913.
Crossref
David HensonAyman Samman TahhanDavid NardoArshed Ali QuyyumiVincent J. Venditto. (2019) Association Between ApoA-I (Apolipoprotein A-I) Immune Complexes and Adverse Cardiovascular Events—Brief Report. Arteriosclerosis, Thrombosis, and Vascular Biology 39:9, pages 1884-1892.
Crossref
Andrei C. Sposito, Helison R. Carmo, Joaquim Barreto, Lufan Sun, Luiz Sergio F. Carvalho, Steve B. Feinstein, Ilaria Zanotti, Anatol Kontush & Alan Remaley. (2019) HDL-Targeted Therapies During Myocardial Infarction. Cardiovascular Drugs and Therapy 33:3, pages 371-381.
Crossref
Eva van der Linden, Karlijn Meeks, Erik Beune, Ama de-Graft Aikins, Juliet Addo, Ellis Owusu-Dabo, Frank P. Mockenhaupt, Silver Bahendeka, Ina Danquah, Matthias B. Schulze, Joachim Spranger, Kerstin Klipstein-Grobusch, Lambert Tetteh Appiah, Liam Smeeth & Charles Agyemang. (2019) Dyslipidaemia among Ghanaian migrants in three European countries and their compatriots in rural and urban Ghana: The RODAM study. Atherosclerosis 284, pages 83-91.
Crossref
C. Michael Gibson, Mathieu Kerneis, Megan K. Yee, Yazan Daaboul, Serge Korjian, Ali Poyan Mehr, Pierluigi Tricoci, John H. Alexander, John J.P. Kastelein, Roxana Mehran, Christoph Bode, Basil S. Lewis, Ravindra Mehta, Danielle Duffy, John Feaster, Majdi Halabi, Dominick J. Angiolillo, Daniel Duerschmied, Ton Oude Ophuis & Bela Merkely. (2019) The CSL112-2001 trial: Safety and tolerability of multiple doses of CSL112 (apolipoprotein A-I [human]), an intravenous formulation of plasma-derived apolipoprotein A-I, among subjects with moderate renal impairment after acute myocardial infarction. American Heart Journal 208, pages 81-90.
Crossref
Mohammed Bourdi, Marcelo Amar, Alan T. Remaley & Pramod S. Terse. (2018) Intravenous toxicity and toxicokinetics of an HDL mimetic, Fx-5A peptide complex, in cynomolgus monkeys. Regulatory Toxicology and Pharmacology 100, pages 59-67.
Crossref
Emily E. Morin, Xiang-An Li & Anna Schwendeman. (2018) HDL in Endocrine Carcinomas: Biomarker, Drug Carrier, and Potential Therapeutic. Frontiers in Endocrinology 9.
Crossref
Diego Estrada-Luna, María Ortiz-Rodriguez, Lizett Medina-Briseño, Elizabeth Carreón-Torres, Jeannett Izquierdo-Vega, Ashutosh Sharma, Juan Cancino-Díaz, Oscar Pérez-Méndez, Helen Belefant-Miller & Gabriel Betanzos-Cabrera. (2018) Current Therapies Focused on High-Density Lipoproteins Associated with Cardiovascular Disease. Molecules 23:11, pages 2730.
Crossref
Rafique M. Islam, Mohsen Pourmousa, Denis Sviridov, Scott M. Gordon, Edward B. Neufeld, Lita A. Freeman, B. Scott PerrinJr.Jr., Richard W. Pastor & Alan T. Remaley. (2018) Structural properties of apolipoprotein A-I mimetic peptides that promote ABCA1-dependent cholesterol efflux. Scientific Reports 8:1.
Crossref
Dan Li, Maria V. Fawaz, Emily E. Morin, Ran Ming, Denis Sviridov, Jie Tang, Rose Ackermann, Karl Olsen, Alan T. Remaley & Anna Schwendeman. (2017) Effect of Synthetic High Density Lipoproteins Modification with Polyethylene Glycol on Pharmacokinetics and Pharmacodynamics. Molecular Pharmaceutics 15:1, pages 83-96.
Crossref
Lita A. Freeman, Stephen J. DemoskyJr.Jr., Monika Konaklieva, Rostislav Kuskovsky, Angel Aponte, Alice F. Ossoli, Scott M. Gordon, Ross F. Koby, Kelly A. Manthei, Min Shen, Boris L. Vaisman, Robert D. Shamburek, Ajit Jadhav, Laura Calabresi, Marjan Gucek, John J.G. Tesmer, Rodney L. Levine & Alan T. Remaley. (2017) Lecithin:Cholesterol Acyltransferase Activation by Sulfhydryl-Reactive Small Molecules: Role of Cysteine-31. Journal of Pharmacology and Experimental Therapeutics 362:2, pages 306-318.
Crossref
Elena Cojocaru, Alexandra Mastaleru, Bogdan Tamba, Raluca Vasile, Razvan Cosmin Tudor, Carmen Valerica Ripa, Roxana Cobzaru & Maria Magdalena Leon. 2017. Recent Trends in Cardiovascular Risks. Recent Trends in Cardiovascular Risks.
Jie Tang, Dan Li, Lindsey Drake, Wenmin Yuan, Sara Deschaine, Emily E. Morin, Rose Ackermann, Karl Olsen, David E. Smith & Anna Schwendeman. (2017) Influence of route of administration and lipidation of apolipoprotein A-I peptide on pharmacokinetics and cholesterol mobilization. Journal of Lipid Research 58:1, pages 124-136.
Crossref
Matthew J. TaylorAalok R. SanjanwalaEmily E. MorinElizabeth Rowland-FisherKyle AndersonAnna SchwendemanWilliam E. Rainey. (2016) Synthetic High-Density Lipoprotein (sHDL) Inhibits Steroid Production in HAC15 Adrenal Cells. Endocrinology 157:8, pages 3122-3129.
Crossref
D.O. Sviridov, S.K. Drake, L.A. Freeman & A.T. Remaley. (2016) Amphipathic polyproline peptides stimulate cholesterol efflux by the ABCA1 transporter. Biochemical and Biophysical Research Communications 471:4, pages 560-565.
Crossref
Judith G. Regensteiner, Sherita Golden, Amy G. Huebschmann, Elizabeth Barrett-Connor, Alice Y. Chang, Deborah Chyun, Caroline S. Fox, Catherine Kim, Nehal Mehta, Jane F. Reckelhoff, Jane E.B. Reusch, Kathryn M. Rexrode, Anne E. Sumner, Francine K. Welty, Nanette K. Wenger & Blair Anton. (2015) Sex Differences in the Cardiovascular Consequences of Diabetes Mellitus. Circulation 132:25, pages 2424-2447.
Crossref
Emily E. Morin, Ling Guo, Anna Schwendeman & Xiang-An Li. (2015) HDL in sepsis – risk factor and therapeutic approach. Frontiers in Pharmacology 6.
Crossref
Anna Schwendeman, Denis O. Sviridov, Wenmin Yuan, Yanhong Guo, Emily E. Morin, Yue Yuan, John Stonik, Lita Freeman, Alice Ossoli, Seth Thacker, Salena Killion, Milton Pryor, Y.Eugene Chen, Scott Turner & Alan T. Remaley. (2015) The effect of phospholipid composition of reconstituted HDL on its cholesterol efflux and anti-inflammatory properties. Journal of Lipid Research 56:9, pages 1727-1737.
Crossref
Anouar Hafiane, John K. Bielicki, Jan O. Johansson & Jacques Genest. (2015) Novel Apo E-Derived ABCA1 Agonist Peptide (CS-6253) Promotes Reverse Cholesterol Transport and Induces Formation of preβ-1 HDL In Vitro. PLOS ONE 10:7, pages e0131997.
Crossref
Marcelo J. A. Amar, Toshihiro Sakurai, Akiko Sakurai-Ikuta, Denis Sviridov, Lita Freeman, Lusana Ahsan & Alan T. Remaley. (2015) A Novel Apolipoprotein C-II Mimetic Peptide That Activates Lipoprotein Lipase and Decreases Serum Triglycerides in Apolipoprotein E–Knockout Mice. Journal of Pharmacology and Experimental Therapeutics 352:2, pages 227-235.
Crossref
Ulrike Schueler, Christine Kaneski, Alan Remaley, Stephen Demosky, Nancy Dwyer, Joan Blanchette-Mackie, John Hanover & Roscoe Brady. 2016. JIMD Reports, Volume 29. JIMD Reports, Volume 29 69 75 .
Oleg F. Sharifov, Xin Xu, Amit Gaggar, Edlue M. Tabengwa, C. Roger White, Mayakonda N. Palgunachari, G. M. Anantharamaiah & Himanshu Gupta. (2014) L-4F Inhibits Lipopolysaccharide-Mediated Activation of Primary Human Neutrophils. Inflammation 37:5, pages 1401-1412.
Crossref
Andreas GilleRachael EastonDenise D’AndreaSamuel D. WrightCharles L. Shear. (2014) CSL112 Enhances Biomarkers of Reverse Cholesterol Transport After Single and Multiple Infusions in Healthy Subjects. Arteriosclerosis, Thrombosis, and Vascular Biology 34:9, pages 2106-2114.
Crossref
A. T. Remaley, G. D. Norata & A. L. Catapano. (2014) Novel concepts in HDL pharmacology. Cardiovascular Research 103:3, pages 423-428.
Crossref
Tarek A. Abd El-Aziz, Rasha H. Mohamed & Hoda A. Hagrass. (2014) Increased risk of premature coronary artery disease in Egyptians with ABCA1 (R219K), CETP (TaqIB), and LCAT (4886C/T) genes polymorphism. Journal of Clinical Lipidology 8:4, pages 381-389.
Crossref
Bronwyn A. Kingwell, M. John Chapman, Anatol Kontush & Norman E. Miller. (2014) HDL-targeted therapies: progress, failures and future. Nature Reviews Drug Discovery 13:6, pages 445-464.
Crossref
Rachael Easton, Andreas Gille, Denise D'Andrea, Roslyn Davis, Samuel D. Wright & Charles Shear. (2014) A multiple ascending dose study of CSL112, an infused formulation of ApoA-I. The Journal of Clinical Pharmacology 54:3, pages 301-310.
Crossref
Lusana Ahsan, Alice F. Ossoli, Lita Freeman, Boris Vaisman, Marcelo J. Amar, Robert D. Shamburek & Alan T. Remaley. 2014. The HDL Handbook. The HDL Handbook 159 194 .
Peter Lerch. 2013. Production of Plasma Proteins for Therapeutic Use. Production of Plasma Proteins for Therapeutic Use 273 282 .
A.T. Remaley. (2013) Tomatoes, lysophosphatidic acid, and the small intestine: new pieces in the puzzle of apolipoprotein mimetic peptides?. Journal of Lipid Research 54:12, pages 3223-3226.
Crossref
Alan T. Remaley. (2013) Apolipoprotein A-II. Arteriosclerosis, Thrombosis, and Vascular Biology 33:2, pages 166-167.
Crossref
Denis O. Sviridov, Alexander M. Andrianov, Ivan V. Anishchenko, John A. Stonik, Marcelo J. A. Amar, Scott Turner & Alan T. Remaley. (2013) Hydrophobic Amino Acids in the Hinge Region of the 5A Apolipoprotein Mimetic Peptide are Essential for Promoting Cholesterol Efflux by the ABCA1 Transporter. Journal of Pharmacology and Experimental Therapeutics 344:1, pages 50-58.
Crossref
Manman SuWeiqin ChangKaiyao ShiDingding WangMingxing WangTianmin XuWeiqun Yan. (2012) Preparation and Activity Analysis of Recombinant Human High-Density Lipoprotein. ASSAY and Drug Development Technologies 10:5, pages 485-491.
Crossref
Anatol Kontush & M. John Chapman. 2011. High‐Density Lipoproteins. High‐Density Lipoproteins 192 303 .
Anatol Kontush & M. John Chapman. 2011. High‐Density Lipoproteins. High‐Density Lipoproteins 423 523 .
D.O. Sviridov, I.Z. Ikpot, J. Stonik, S.K. Drake, M. Amar, D.O. Osei-Hwedieh, G. Piszczek, S. Turner & A.T. Remaley. (2011) Helix stabilization of amphipathic peptides by hydrocarbon stapling increases cholesterol efflux by the ABCA1 transporter. Biochemical and Biophysical Research Communications 410:3, pages 446-451.
Crossref
Xavier Rousset, Robert Shamburek, Boris Vaisman, Marcelo Amar & Alan T. Remaley. (2011) Lecithin Cholesterol Acyltransferase: An Anti- or Pro-atherogenic Factor?. Current Atherosclerosis Reports 13:3, pages 249-256.
Crossref
Yoshitaka Sekine, Kazuhiro Suzuki & Alan T. Remaley. (2010) HDL and sphingosine‐1‐phosphate activate stat3 in prostate cancer DU145 cells via ERK1/2 and S1P receptors, and promote cell migration and invasion. The Prostate 71:7, pages 690-699.
Crossref
Xavier Rousset, Boris Vaisman, Bruce Auerbach, Brian R. Krause, Reyn Homan, John Stonik, Gyorgy Csako, Robert Shamburek & Alan T. Remaley. (2010) Effect of Recombinant Human Lecithin Cholesterol Acyltransferase Infusion on Lipoprotein Metabolism in Mice. Journal of Pharmacology and Experimental Therapeutics 335:1, pages 140-148.
Crossref
Yoshitaka Sekine, Steve J. Demosky, John A. Stonik, Yosuke Furuya, Hidekazu Koike, Kazuhiro Suzuki & Alan T. Remaley. (2010) High-Density Lipoprotein Induces Proliferation and Migration of Human Prostate Androgen–Independent Cancer Cells by an ABCA1-Dependent Mechanism. Molecular Cancer Research 8:9, pages 1284-1294.
Crossref
Anne E. Sumner, Jie Zhou, Ayo Doumatey, Omoye E. Imoisili, Albert Amoah, Joseph Acheampong, Johnnie Oli, Thomas Johnson, Clement Adebamowo & Charles N. Rotimi. (2010) Low HDL-cholesterol with normal triglyceride levels is the most common lipid pattern in West Africans and African Americans with Metabolic Syndrome: Implications for cardiovascular disease prevention. Global Heart 5:3, pages 75.
Crossref
Marcelo J. A. Amar, Wilissa D'Souza, Scott Turner, Stephen Demosky, Denis Sviridov, John Stonik, Jayraz Luchoomun, Jason Voogt, Marc Hellerstein, Dmitri Sviridov & Alan T. Remaley. (2010) 5A Apolipoprotein Mimetic Peptide Promotes Cholesterol Efflux and Reduces Atherosclerosis in Mice. Journal of Pharmacology and Experimental Therapeutics 334:2, pages 634-641.
Crossref
Wilissa D'SouzaJohn A. StonikAndrew MurphySteven J. DemoskyAmar A. SethiXiao L. MooreJaye Chin-DustingAlan T. RemaleyDmitri Sviridov. (2010) Structure/Function Relationships of Apolipoprotein A-I Mimetic Peptides. Circulation Research 107:2, pages 217-227.
Crossref
Dmitri Sviridov. (2010) Introduction. Clinical and Experimental Pharmacology and Physiology 37:7, pages 700-702.
Crossref
Jerzy‐Roch Nofer, Martin F Brodde & Beate E Kehrel. (2010) High‐density lipoproteins, platelets and the pathogenesis of atherosclerosis. Clinical and Experimental Pharmacology and Physiology 37:7, pages 726-735.
Crossref
Armando J Mendez. (2010) The promise of apolipoprotein A-I mimetics. Current Opinion in Endocrinology, Diabetes & Obesity 17:2, pages 171-176.
Crossref
Fatiha TabetAlan T. RemaleyAude I. SegalinyJonathan MilletLing YanShirley NakhlaPhilip J. BarterKerry-Anne RyeGilles Lambert. (2010) The 5A Apolipoprotein A-I Mimetic Peptide Displays Antiinflammatory and Antioxidant Properties In Vivo and In Vitro. Arteriosclerosis, Thrombosis, and Vascular Biology 30:2, pages 246-252.
Crossref
. (2009) Current World Literature. Current Opinion in Endocrinology, Diabetes & Obesity 16:2, pages 189-202.
Crossref
Xavier Rousset, Boris Vaisman, Marcelo Amar, Amar A Sethi & Alan T Remaley. (2009) Lecithin: cholesterol acyltransferase – from biochemistry to role in cardiovascular disease. Current Opinion in Endocrinology, Diabetes & Obesity 16:2, pages 163-171.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.